NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

8696	Companies
150952	Keywords
86602	Articles
81042	Press releases

Home
Companies
NanoViricides, Inc.

BRIEF

published on 01/13/2025 at 12:35, 4 months 21 days ago

NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase

NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
PRESS RELEASE

published on 01/13/2025 at 12:30, 4 months 21 days ago

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections

NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
BRIEF

published on 01/08/2025 at 12:35, 4 months 26 days ago

Antiviraux à large spectre : une nécessité face aux multiples menaces virales

NanoViricides NV-387 Antiviraux À Large Spectre Virus À ARN Résistance Virale
BRIEF

published on 01/08/2025 at 12:35, 4 months 26 days ago

Broad-Spectrum Antivirals: A Necessity Amid Multiple Viral Threats

NanoViricides NV-387 Broad-spectrum Antivirals RNA Viruses Viral Resistance
PRESS RELEASE

published on 01/08/2025 at 12:30, 4 months 26 days ago

Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
NanoViricides, Inc. President Dr. Anil Diwan comments on multiple pandemic-causing viruses worldwide, highlighting NV-387's broad-spectrum antiviral capabilities

NanoViricides NV-387 Antiviral Broad-spectrum Pandemic
BRIEF

published on 12/23/2024 at 12:35, 5 months 11 days ago

NanoViricides positionne le NV-387 comme un acteur clé dans la lutte contre la grippe aviaire

NanoViricides NV-387 Virus H5N1 Médicament Antiviral Grippe Aviaire
BRIEF

published on 12/23/2024 at 12:35, 5 months 11 days ago

NanoViricides Positions NV-387 as Key Player Against Bird Flu

NanoViricides NV-387 Antiviral Drug H5N1 Virus Bird Flu
PRESS RELEASE

published on 12/23/2024 at 12:30, 5 months 11 days ago

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
NanoViricides, Inc. announces that its antiviral drug candidate NV-387 shows promise in combating potential bird flu pandemic. The drug mimics essential host-side features, making it hard for the virus to escape

NanoViricides NV-387 Antiviral Drug H5N1 Bird Flu Pandemic
BRIEF

published on 11/15/2024 at 12:35, 6 months 18 days ago

NanoViricides Advances NV-387 to Phase II Trials for Multiple Viral Infections

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Drug
BRIEF

published on 11/15/2024 at 12:35, 6 months 18 days ago

NanoViricides fait passer le NV-387 aux essais de phase II pour le traitement de multiples infections virales

NanoViricides NV-387 Rapport Financier Essais Cliniques Médicament Antiviral

Accesswire

Published on 06/04/2025 at 01:05, 40 minutes ago

BEWHERE HOLDINGS INC. (Listed on the TSX Venture Exchange - Stock Symbol “BEW”) Announces Plans to Repurchase Common Shares
Published on 06/04/2025 at 00:55, 50 minutes ago

Cypher Metaverse Inc. Announces Financing
Published on 06/03/2025 at 23:45, 2 hours ago

Eagle Royalties - Clarifying News Release
Published on 06/03/2025 at 23:00, 2 hours 45 minutes ago

NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/03/2025 at 20:05, 5 hours 40 minutes ago

FINDEV INC. Updates Ex-Dividend Date

View all ACCESSWIRE

EQS Group

Published on 06/03/2025 at 19:23, 6 hours 22 minutes ago

thyssenkrupp nucera Signs FEED Study for a 600 MW Green Hydrogen Project in Europe
Published on 06/03/2025 at 19:18, 6 hours 27 minutes ago

EQS-Adhoc: thyssenkrupp nucera Signs FEED Study for a 600 MW Green Hydrogen Project in Europe
Published on 06/03/2025 at 18:40, 7 hours 4 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 06/03/2025 at 18:05, 7 hours 40 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 06/03/2025 at 17:45, 8 hours ago

Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTES

Les Echos

Published on 06/03/2025 at 18:30, 7 hours 15 minutes ago

ABEO et VOGO, l’alliance de deux leaders français dans le domaine du sport. Projet d’offre publique volontaire par ABEO visant les actions VOGO
Published on 06/03/2025 at 18:30, 7 hours 15 minutes ago

ABEO and VOGO, the alliance of two French leaders in the sports sector. Proposed voluntary public offer by ABEO for the shares of VOGO
Published on 06/03/2025 at 17:45, 8 hours ago

Carrefour initie la cession de 7% du capital de Carmila par voie d’un placement accéléré
Published on 06/03/2025 at 17:45, 8 hours ago

Carrefour initiates the disposal of 7% of Carmila’s share capital through an accelerated book-building
Published on 06/03/2025 at 17:45, 8 hours ago

Informations relatives au nombre total de droits de vote et d’actions

View all LES ECHOS COMFI WIRE